Determined to drive change in immuno-oncology

Our Mission
At Phio Pharmaceuticals, our mission is to develop innovative cancer treatments that overcome tumor immunosuppression and weaponize the immune system against cancer without genetic modification.

Our Science
We are dedicated to maximizing the value of our INTASYL™ self-delivering technology for immuno-oncology.
Our Pipeline
Our INTASYL™ self-delivering RNA inference (RNAi) technology activates immune cells to better recognize and kill cancer cells. It does so by silencing genes and reducing the expression of proteins that tumors use to escape the immune response.
News
Join Us
If you share our determination to look beyond established treatments and to achieve outcomes that were once out of reach, join us. You can learn more about joining the Phio team by contacting hr@phiopharma.com or by visiting us on LinkedIn to see our current employment opportunities. Or, click below to learn more about us and our team.
Contact Us
Get in touch with us.
*=required